HEADER HORMONE RECEPTOR 28-NOV-11 3UU7 TITLE CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BISPHENOL-A COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN (RESIDUES 302-552); COMPND 5 SYNONYM: ER, ER-ALPHA, ESTRADIOL RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY COMPND 6 3 GROUP A MEMBER 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: ESTROGEN RECEPTOR; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: LIGAND BINDING DOMAIN (RESIDUES 302-552); COMPND 13 SYNONYM: ER, ER-ALPHA, ESTRADIOL RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY COMPND 14 3 GROUP A MEMBER 1; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1; COMPND 19 CHAIN: F, G; COMPND 20 FRAGMENT: COACTIVATOR PEPTIDE SRC-1; COMPND 21 SYNONYM: NCOA-1, CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 74, BHLHE74, COMPND 22 PROTEIN HIN-2, RIP160, RENAL CARCINOMA ANTIGEN NY-REN-52, STEROID COMPND 23 RECEPTOR COACTIVATOR 1, SRC-1; COMPND 24 EC: 2.3.1.48; COMPND 25 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET32A; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: ESR1, ESR, NR3A1; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET32A; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606; SOURCE 26 OTHER_DETAILS: SYNTHESIZED PEPTIDE KEYWDS LIGAND-BINDING DOMAIN OF NUCLEAR HORMONE RECEPTOR, HORMONE RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR V.DELFOSSE,M.GRIMALDI,W.BOURGUET REVDAT 4 06-DEC-23 3UU7 1 REMARK REVDAT 3 13-SEP-23 3UU7 1 REMARK SEQADV HETSYN LINK REVDAT 2 26-SEP-12 3UU7 1 JRNL REVDAT 1 22-AUG-12 3UU7 0 JRNL AUTH V.DELFOSSE,M.GRIMALDI,J.L.PONS,A.BOULAHTOUF,A.LE MAIRE, JRNL AUTH 2 V.CAVAILLES,G.LABESSE,W.BOURGUET,P.BALAGUER JRNL TITL STRUCTURAL AND MECHANISTIC INSIGHTS INTO BISPHENOLS ACTION JRNL TITL 2 PROVIDE GUIDELINES FOR RISK ASSESSMENT AND DISCOVERY OF JRNL TITL 3 BISPHENOL A SUBSTITUTES. JRNL REF PROC.NATL.ACAD.SCI.USA V. 109 14930 2012 JRNL REFN ISSN 0027-8424 JRNL PMID 22927406 JRNL DOI 10.1073/PNAS.1203574109 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.53 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 24610 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1231 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.5366 - 4.5667 1.00 2641 140 0.1909 0.2176 REMARK 3 2 4.5667 - 3.6252 1.00 2633 138 0.1742 0.1989 REMARK 3 3 3.6252 - 3.1671 1.00 2595 137 0.2020 0.2429 REMARK 3 4 3.1671 - 2.8775 1.00 2606 137 0.2132 0.2723 REMARK 3 5 2.8775 - 2.6713 1.00 2597 137 0.2300 0.2895 REMARK 3 6 2.6713 - 2.5138 1.00 2585 136 0.2257 0.2556 REMARK 3 7 2.5138 - 2.3879 1.00 2553 134 0.2298 0.2660 REMARK 3 8 2.3879 - 2.2840 0.99 2586 136 0.2416 0.2818 REMARK 3 9 2.2840 - 2.1961 0.99 2583 136 0.2654 0.3525 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.37 REMARK 3 B_SOL : 49.37 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.680 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 10.01390 REMARK 3 B22 (A**2) : -2.26260 REMARK 3 B33 (A**2) : -7.75130 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 6.47860 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 4005 REMARK 3 ANGLE : 0.616 5429 REMARK 3 CHIRALITY : 0.044 641 REMARK 3 PLANARITY : 0.005 676 REMARK 3 DIHEDRAL : 17.472 1473 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3UU7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-DEC-11. REMARK 100 THE DEPOSITION ID IS D_1000069213. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-MAY-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93340 REMARK 200 MONOCHROMATOR : DIAMOND (111), GE(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24610 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.196 REMARK 200 RESOLUTION RANGE LOW (A) : 46.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.01060 REMARK 200 FOR THE DATA SET : 8.4300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.43200 REMARK 200 FOR SHELL : 2.960 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: PDB ENTRY 3L03 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 300 MM NACL, 100 MM NAHEPES PH 7.75, REMARK 280 30% PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.79000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6260 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, F, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 SER A 305 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 LEU B 469 REMARK 465 GLU B 470 REMARK 465 GLU B 471 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 ARG F 686 REMARK 465 HIS F 687 REMARK 465 GLY F 697 REMARK 465 SER F 698 REMARK 465 ARG G 686 REMARK 465 HIS G 687 REMARK 465 GLY G 697 REMARK 465 SER G 698 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 306 CG CD1 CD2 REMARK 470 GLU A 330 CG CD OE1 OE2 REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 LYS A 467 CG CD CE NZ REMARK 470 SER A 468 OG REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 LYS A 472 CG CD CE NZ REMARK 470 LYS A 492 CG CD CE NZ REMARK 470 LYS A 531 CG CD CE NZ REMARK 470 ASN A 532 CG OD1 ND2 REMARK 470 VAL A 533 CG1 CG2 REMARK 470 ARG A 548 CG CD NE CZ NH1 NH2 REMARK 470 THR B 334 OG1 CG2 REMARK 470 ARG B 335 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 397 CG CD OE1 OE2 REMARK 470 LYS B 472 CG CD CE NZ REMARK 470 LYS B 531 CG CD CE NZ REMARK 470 VAL B 533 CG1 CG2 REMARK 470 ARG B 548 CG CD NE CZ NH1 NH2 REMARK 470 LYS F 688 CG CD CE NZ REMARK 470 GLU F 696 CG CD OE1 OE2 REMARK 470 LYS G 688 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU B 330 CD REMARK 480 THR B 334 C REMARK 480 PRO B 336 N REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 548 -98.79 66.46 REMARK 500 THR B 334 48.22 -106.87 REMARK 500 PHE B 337 112.55 177.32 REMARK 500 LEU B 408 74.15 -152.77 REMARK 500 VAL B 533 -70.41 -60.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2OH A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2OH B 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3UUA RELATED DB: PDB REMARK 900 RELATED ID: 3UUC RELATED DB: PDB REMARK 900 RELATED ID: 3UUD RELATED DB: PDB DBREF 3UU7 A 302 552 UNP P03372 ESR1_HUMAN 302 552 DBREF 3UU7 B 302 552 UNP P03372 ESR1_HUMAN 302 552 DBREF 3UU7 F 686 698 UNP Q15788 NCOA1_HUMAN 686 698 DBREF 3UU7 G 686 698 UNP Q15788 NCOA1_HUMAN 686 698 SEQADV 3UU7 SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 3UU7 SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 251 LYS LYS ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN SEQRES 2 A 251 MET VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU SEQRES 3 A 251 TYR SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SEQRES 4 A 251 SER MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU SEQRES 5 A 251 LEU VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY SEQRES 6 A 251 PHE VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU SEQRES 7 A 251 GLU CSO ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL SEQRES 8 A 251 TRP ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA SEQRES 9 A 251 PRO ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS CSO VAL SEQRES 10 A 251 GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SEQRES 11 A 251 SER SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU SEQRES 12 A 251 PHE VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY SEQRES 13 A 251 VAL TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU SEQRES 14 A 251 GLU LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR SEQRES 15 A 251 ASP THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR SEQRES 16 A 251 LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU SEQRES 17 A 251 ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET SEQRES 18 A 251 GLU HIS LEU TYR SER MET LYS CYS LYS ASN VAL VAL PRO SEQRES 19 A 251 LEU SER ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG SEQRES 20 A 251 LEU HIS ALA PRO SEQRES 1 B 251 LYS LYS ASN SER LEU ALA LEU SER LEU THR ALA ASP GLN SEQRES 2 B 251 MET VAL SER ALA LEU LEU ASP ALA GLU PRO PRO ILE LEU SEQRES 3 B 251 TYR SER GLU TYR ASP PRO THR ARG PRO PHE SER GLU ALA SEQRES 4 B 251 SER MET MET GLY LEU LEU THR ASN LEU ALA ASP ARG GLU SEQRES 5 B 251 LEU VAL HIS MET ILE ASN TRP ALA LYS ARG VAL PRO GLY SEQRES 6 B 251 PHE VAL ASP LEU THR LEU HIS ASP GLN VAL HIS LEU LEU SEQRES 7 B 251 GLU CSO ALA TRP LEU GLU ILE LEU MET ILE GLY LEU VAL SEQRES 8 B 251 TRP ARG SER MET GLU HIS PRO GLY LYS LEU LEU PHE ALA SEQRES 9 B 251 PRO ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS CSO VAL SEQRES 10 B 251 GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU ALA THR SEQRES 11 B 251 SER SER ARG PHE ARG MET MET ASN LEU GLN GLY GLU GLU SEQRES 12 B 251 PHE VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SER GLY SEQRES 13 B 251 VAL TYR THR PHE LEU SER SER THR LEU LYS SER LEU GLU SEQRES 14 B 251 GLU LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS ILE THR SEQRES 15 B 251 ASP THR LEU ILE HIS LEU MET ALA LYS ALA GLY LEU THR SEQRES 16 B 251 LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU LEU LEU SEQRES 17 B 251 ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS GLY MET SEQRES 18 B 251 GLU HIS LEU TYR SER MET LYS CSO LYS ASN VAL VAL PRO SEQRES 19 B 251 LEU SER ASP LEU LEU LEU GLU MET LEU ASP ALA HIS ARG SEQRES 20 B 251 LEU HIS ALA PRO SEQRES 1 F 13 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER SEQRES 1 G 13 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER MODRES 3UU7 CSO A 381 CYS S-HYDROXYCYSTEINE MODRES 3UU7 CSO A 417 CYS S-HYDROXYCYSTEINE MODRES 3UU7 CSO B 381 CYS S-HYDROXYCYSTEINE MODRES 3UU7 CSO B 417 CYS S-HYDROXYCYSTEINE MODRES 3UU7 CSO B 530 CYS S-HYDROXYCYSTEINE HET CSO A 381 11 HET CSO A 417 7 HET CSO B 381 11 HET CSO B 417 7 HET CSO B 530 7 HET 2OH A 1 17 HET 2OH B 1 17 HETNAM CSO S-HYDROXYCYSTEINE HETNAM 2OH 4,4'-PROPANE-2,2-DIYLDIPHENOL HETSYN 2OH 4,4'-ISOPROPYLIDENEDIPHENOL; BISPHENOL A FORMUL 1 CSO 5(C3 H7 N O3 S) FORMUL 5 2OH 2(C15 H16 O2) FORMUL 7 HOH *165(H2 O) HELIX 1 1 LEU A 306 LEU A 310 5 5 HELIX 2 2 THR A 311 GLU A 323 1 13 HELIX 3 3 SER A 338 LYS A 362 1 25 HELIX 4 4 THR A 371 SER A 395 1 25 HELIX 5 5 ASN A 413 CSO A 417 5 5 HELIX 6 6 GLY A 420 ASN A 439 1 20 HELIX 7 7 GLN A 441 SER A 456 1 16 HELIX 8 8 SER A 468 ALA A 493 1 26 HELIX 9 9 THR A 496 ASN A 532 1 37 HELIX 10 10 SER A 537 HIS A 547 1 11 HELIX 11 11 SER B 305 LEU B 310 5 6 HELIX 12 12 THR B 311 GLU B 323 1 13 HELIX 13 13 SER B 338 LYS B 362 1 25 HELIX 14 14 THR B 371 SER B 395 1 25 HELIX 15 15 ARG B 412 LYS B 416 1 5 HELIX 16 16 MET B 421 MET B 438 1 18 HELIX 17 17 GLN B 441 SER B 456 1 16 HELIX 18 18 GLY B 457 PHE B 461 5 5 HELIX 19 19 ASP B 473 ALA B 493 1 21 HELIX 20 20 THR B 496 LYS B 531 1 36 HELIX 21 21 SER B 537 ALA B 546 1 10 HELIX 22 22 ILE F 689 GLU F 696 1 8 HELIX 23 23 ILE G 689 GLU G 696 1 8 SHEET 1 A 2 LEU A 402 ALA A 405 0 SHEET 2 A 2 LEU A 408 LEU A 410 -1 O LEU A 410 N LEU A 402 SHEET 1 B 2 LYS B 401 ALA B 405 0 SHEET 2 B 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 LINK C GLU A 380 N CSO A 381 1555 1555 1.32 LINK C CSO A 381 N ALA A 382 1555 1555 1.31 LINK C LYS A 416 N CSO A 417 1555 1555 1.33 LINK C CSO A 417 N VAL A 418 1555 1555 1.32 LINK C GLU B 380 N CSO B 381 1555 1555 1.32 LINK C CSO B 381 N ALA B 382 1555 1555 1.31 LINK C LYS B 416 N CSO B 417 1555 1555 1.32 LINK C CSO B 417 N VAL B 418 1555 1555 1.31 LINK C LYS B 529 N CSO B 530 1555 1555 1.33 LINK C CSO B 530 N LYS B 531 1555 1555 1.31 CISPEP 1 PRO B 336 PHE B 337 0 -1.36 SITE 1 AC1 7 LEU A 346 ALA A 350 GLU A 353 ARG A 394 SITE 2 AC1 7 MET A 421 ILE A 424 LEU A 525 SITE 1 AC2 7 LEU B 346 ALA B 350 GLU B 353 ARG B 394 SITE 2 AC2 7 MET B 421 ILE B 424 HIS B 524 CRYST1 54.850 81.580 58.520 90.00 110.68 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018232 0.000000 0.006882 0.00000 SCALE2 0.000000 0.012258 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018265 0.00000